Perspective Therapeutics, Inc. (CATX): Depreciation & Amortization
$3.25M
Year ended 2025-12-31
$4.05M
Trailing 12 months to 2026-06-30
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.25M | +41.0% | 2026-03-16, From 2025-01-01 |
| 2024-12-31 | $2.31M | +133.9% | 2026-03-16, From 2024-01-01 |
| 2023-12-31 | $986.0K | n/a | 2025-03-28, From 2023-01-01 |
| No annual figure between 2017-06-30 and 2023-12-31. | |||
| 2017-06-30 | $68.0K | -85.6% | 2017-09-28, From 2016-07-01 |
| 2016-06-30 | $471.0K | -18.2% | 2017-09-28, From 2015-07-01 |
| 2015-06-30 | $576.0K | -16.0% | 2017-09-28, From 2014-07-01 |
| 2014-06-30 | $685.4K | -7.3% | 2016-09-09, From 2013-07-01 |
| 2013-06-30 | $739.1K | -12.7% | 2015-09-14, From 2012-07-01 |
| 2012-06-30 | $847.1K | -4.7% | 2013-09-30, From 2011-07-01 |
| 2011-06-30 | $888.6K | n/a | 2012-10-26, From 2010-07-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Perspective Therapeutics, Inc. (CATX) | 2025-12-31 | $3.25M | +41.0% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | $3.02M | -14.6% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $13.84M | -2.6% |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | $633.0K | -20.4% |
| Contineum Therapeutics, Inc. (CTNM) | 2025-12-31 | $323.0K | +25.2% |
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | $129.0K | 0.0% |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 2025-12-31 | $1.90M | -34.5% |
| Macrogenics Inc (MGNX) | 2025-12-31 | $7.17M | -4.9% |
| Annexon, Inc. (ANNX) | 2025-12-31 | $2.17M | +0.7% |
Compare CATX, ARCT, NATR, PHAT side by side · Screen every company in Pharmaceutical Preparations ↗